Aurora Spine launches Dexa-L fusion device

Executive Summary

• Aurora Spine Corp. has officially launched the Dexa-L, a stand-alone anterior lumbar interbody fusion (ALIF) device.
• The device is part of the company's patented Dexa technology platform, which features bone-density matched implants designed to mimic patient bone quality.
• Initial surgeries have already been performed, with Dr. Daniel Barba in San Diego, California, serving as the first U.S. surgeon to implant the system.

Key Details

• Product Name: Dexa-L anterior lumbar interbody fusion device.
• Technology Platform: Part of the patented Dexa technology platform, described as the world's first bone density matched implants.
• Key Feature: It is the first spinal implant designed as a bone-mimicking structural implant, allowing surgeons to match the modulus of the cage to the patient's specific bone density and quality.
• Clinical Application: Designed for anterior lumbar interbody fusion procedures; specifically targets patients with poor bone quality (osteopenia or osteoporosis) who are typically not good candidates for standard fusion.
• First Implant: Dr. Daniel Barba of San Diego, Calif., was the first surgeon to use the Dexa-L stand-alone ALIF system in the United States.
• Market Context: The company cites CDC estimates that nearly half of the U.S. population over 50 has low bone mass, creating a significant need for implants that match bone density.
• Technical Benefits: Internal testing of the cervical platform (Dexa-C) suggests the technology could lead to less subsidence.
• Related Products: Builds on the momentum of Dexa-C, a cervical fusion implant already utilized in numerous institutions throughout the U.S.

Notable Quotes

• Dr. Daniel Barba (Surgeon): "This novel technology allows me to match the modulus of the cage to the bone density of each of my patients. This has enabled me to expand my indications for lumbar fusion within patients that would normally not be a good candidate due to their poor bone quality."
• Ron Eckels (U.S. Director of Spine, Aurora Spine): "The Dexa-L stand-alone ALIF system now allows surgeons the opportunity to treat patients who have osteopenia or osteoporosis, as well as those who have normal bone density but still need surgery. The days of not matching an implant modulus to the patient are behind us."
• Laszlo Garamszegi (Chief Technology Officer, Aurora Spine): "Dexa-L provides a stand-alone ALIF option for patients with less-than-optimal bone quality. Importantly, this technology could lead to less subsidence... bringing the same patient-specific approach to the lumbar spine."